Search clinical trials for: Placebo Oral
Total 59497 results
-
Merck Sharp & Dohme LLCCompleted
-
Isfahan University of Medical SciencesCompletedLocal AnesthesiaIran, Islamic Republic of
-
Georgetown UniversityNational Institute of Mental Health (NIMH); Washington D.C. Veterans Affairs...CompletedSchizophreniaUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Congenital Amegakaryocytic Thrombocytopenia | Severe Congenital Neutropenia | Diamond-blackfan AnemiaUnited States
-
National University Hospital, SingaporeUnknownAcute Lymphoblastic Leukemia (ALL)Singapore, Malaysia
-
The Faculty Hospital Na BulovceCompletedSmall Bowel Obstruction | Acute Appendicitis | Perforated Gastroduodenal UlcerCzech Republic
-
University of Cape TownRecruitingHIV | Disseminated TuberculosisSouth Africa
-
National Cancer Institute (NCI)RecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Locally Advanced Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic Adenocarcinoma | Unresectable Pancreatic AdenocarcinomaUnited States
-
The University of Texas Medical Branch, GalvestonNational Institute of General Medical Sciences (NIGMS)Completed
-
Surface Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterAmgenCompletedLymphomaUnited States
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer | Solid Tumor | Non-small Cell Lung Cancer
-
University of ArkansasNational Institute on Drug Abuse (NIDA)Completed
-
University of California, IrvineWithdrawnAnesthetized Healthy Patients (ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries | Anesthetized Patient With Severe Systemic Disease (ASA 3 or 4)United States
-
SanofiCompleted
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Hematologic MalignancyUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Juno Therapeutics, Inc.CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of Sao PauloUnknown
-
St. Jude Children's Research HospitalTerminatedAcute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Myeloid Sarcoma | Chronic Myelogenous Leukemia (CML) | Non-Hodgkin Lymphoma (NHL) | Juvenile Myelomonocytic Leukemia (JMML)United States
-
Avanir PharmaceuticalsSyneos HealthCompletedPseudobulbar Affect (PBA)United States, Argentina, Brazil
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, United Kingdom
-
National Institute of Allergy and Infectious Diseases...Glaxo Wellcome; UpjohnCompletedHIV Infections | Toxoplasmosis, CerebralUnited States
-
NSABP Foundation IncNational Cancer Institute (NCI); Northern California Cancer CenterCompleted
-
AbbottCompleted
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Colorectal Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Carcinoma of Unknown PrimaryUnited States
-
GlaxoSmithKlineCompleted
-
Henan Cancer HospitalRecruitingAcute Myeloid Leukemia | Thalidomide | Maintenance Treatment | Minor Residue Disease | Interferon-α-1b | Interleukin-2 | Venentoclax | AzacitidineChina
-
UNICANCERFederation Francophone de Cancerologie DigestiveCompletedCombination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon CancerColorectal CancerFrance
-
Columbia UniversityWithdrawn
-
Clark StanfordWithdrawn
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities and other conditionsUnited States, Canada, Australia
-
Prof. Dr. M. Dreyling (co-chairman)ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...UnknownMantle Cell LymphomaFrance, Germany
-
Jonsson Comprehensive Cancer CenterNot yet recruitingDiffuse Hemispheric Glioma, H3 G34-MutantUnited States
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca; University of CambridgeTerminatedDrug-Related Side Effects and Adverse Reactions | Cardiovascular System DiseaseUnited Kingdom
-
M.D. Anderson Cancer CenterNational Institute of Nursing Research (NINR)Active, not recruitingAdvanced Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
University of ArkansasNational Institute on Drug Abuse (NIDA)Completed
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
Fred Hutchinson Cancer CenterRecruitingNon-Neoplastic Hematologic and Lymphocytic DisorderUnited States
-
University of PennsylvaniaChildren's Hospital of Philadelphia; Crohn's and Colitis FoundationCompletedCrohn's DiseaseUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
St. Jude Children's Research HospitalIncyte Corporation; Amgen; ServierActive, not recruitingAcute Lymphoblastic Leukemia | Acute Lymphoblastic LymphomaUnited States, Australia
-
University of TennesseeTerminated
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Romania, Italy, Spain, Belgium, Denmark, Estonia, Sweden, Austria, Latvia, United Kingdom, Ukraine, Russian Federation, Greece, Czech Republic, Slovenia, Norway, Lithuania, Slovakia
-
AstraZenecaCompleted
-
University of British ColumbiaBoehringer Ingelheim; Abbott; CIHR Canadian HIV Trials NetworkCompleted